Beaufrère A, Calderaro J, Paradis V. Combined hepatocellular-cholangiocarcinoma: An update. J Hepatol. 2021;74:1212–24.

Article  PubMed  Google Scholar 

Chu KJ, Kawaguchi Y, Wang H, Jiang XQ, Hasegawa K. Update on the diagnosis and treatment of combined hepatocellular cholangiocarcinoma. J Clin Transl Hepatol. 2024;12:210–7.

CAS  PubMed  Google Scholar 

Sciarra A, Park YN, Sempoux C. Updates in the diagnosis of combined hepatocellular-cholangiocarcinoma. Hum Pathol. 2020;96:48–55.

Article  CAS  PubMed  Google Scholar 

Komuta M, Yeh MM. A review on the update of combined hepatocellular cholangiocarcinoma. Semin Liver Dis. 2020;40:124–30.

Article  PubMed  Google Scholar 

Ye L, Schneider JS, Ben Khaled N, et al. Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management. Liver Cancer. 2024;13:6–28.

Article  CAS  PubMed  Google Scholar 

Yano H, Iemura A, Haramaki M, et al. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions. J Hepatol. 1996;24:413–22.

Article  CAS  PubMed  Google Scholar 

Murakami T, Yano H, Maruiwa M, Sugihara S, Kojiro M. Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice. Hepatology. 1987;7:551–6.

Article  CAS  PubMed  Google Scholar 

Atlı Şekeroğlu Z, Şekeroğlu V. A review on patient-derived 3D micro cancer approach for drug screen in personalized cancer medicine. Curr Cancer Drug Targets. 2024;25(2):118–30.

Article  Google Scholar 

Weeber F, Ooft SN, Dijkstra KK, Voest EE. Tumor organoids as a pre-clinical cancer model for drug discovery. Cell Chem Biol. 2017;24:1092–100.

Article  CAS  PubMed  Google Scholar 

Sato K, Zhang W, Safarikia S, et al. Organoids and spheroids as models for studying cholestatic liver injury and cholangiocarcinoma. Hepatology. 2021;74:491–502.

Article  PubMed  Google Scholar 

Broutier L, Mastrogiovanni G, Verstegen MM, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23:1424–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao Y, Zhou Z, Lu S, et al. Chemokine CCL15 mediates migration of human bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma. Stem Cells. 2016;34:1112–22.

Article  CAS  PubMed  Google Scholar 

Calderaro J, Di Tommaso L, Maillé P, et al. Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma. J Hepatol. 2022;77:1586–97.

Article  CAS  PubMed  Google Scholar 

Sasaki M, Sato Y, Nakanuma Y. Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma? Histopathology. 2022;80:859–68.

Article  CAS  PubMed  Google Scholar 

Xue R, Chen L, Zhang C, et al. Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes. Cancer Cell. 2019;35:932-947.e938.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sachs N, de Ligt J, Kopper O, et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018;172:373-386.e310.

Article  CAS  PubMed  Google Scholar 

Chen L, Zhang C, Xue R, et al. Deep whole-genome analysis of 494 hepatocellular carcinomas. Nature. 2024;627:586–93.

Article  CAS  PubMed  Google Scholar 

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017;169:1327–1341.e1323. https://pubmed.ncbi.nlm.nih.gov/28622513.

Totoki Y, Tatsuno K, Yamamoto S, et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet. 2011;43:464–9.

Article  CAS  PubMed  Google Scholar 

Yang Z, Liu J, Xue F, Zhang L, Xue H, Wu Y, Bai S, et al. Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis. Ann Hepatol. 2023;28: 100898.

Article  CAS  PubMed  Google Scholar 

Wang L, Zhu H, Zhao Y, et al. Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience. J Transl Med. 2020;18:273.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andraus W, Tustumi F, de Meira Junior JD, et al. Molecular profile of intrahepatic cholangiocarcinoma. Int J Mol Sci. 2023;25(1):461.

Article  PubMed  PubMed Central  Google Scholar 

Joseph NM, Tsokos CG, Umetsu SE, et al. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma. J Pathol. 2019;248:164–78.

Article  CAS  PubMed  Google Scholar 

Xian L, Zhao P, Chen X, et al. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer. Cell Oncol (Dordr). 2022;45:1019–36.

Article  CAS  PubMed  Google Scholar 

Yu JH, Ma S. Organoids as research models for hepatocellular carcinoma. Exp Cell Res. 2022;411:112987.

Article  CAS  PubMed  Google Scholar 

Zhang YZ, Liu YC, Su T, Shi JN, Huang Y, Liang B. Current advances and future directions in combined hepatocellular and cholangiocarcinoma. Gastroenterol Rep (Oxf). 2024;12:goae031.

Article  PubMed  PubMed Central  Google Scholar